Study Suggests Halving Fertility Treatment Costs Could More Than Double Births
A major international study presented at the ESHRE annual meeting found that halving patient out-of-pocket costs was associated with a 2.67-fold increase in births achieved through assisted reproductive technology (ART).
An international study has indicated that reducing patient out-of-pocket expenses for fertility treatments by half could lead to a significant increase in births via assisted reproductive technology (ART). The findings, presented on July 6, 2026, in London, suggest a 2.67-fold rise in ART-achieved births when treatment costs are halved.
The research was unveiled at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE). This large-scale study highlights the impact of financial accessibility on the utilization and success rates of fertility treatments across multiple countries.
According to the study's analysis, a substantial decrease in the financial burden on patients appears to make fertility treatments more attainable for a larger segment of the population. This increased access may directly correlate with a more than doubled number of successful pregnancies initiated and carried to term through ART.
While further investigation may be required to fully elucidate the pathways influenced by cost reduction, the study underscores the critical role of mitigating financial barriers in enhancing the availability and effectiveness of fertility care on a global scale.